Efficacy of tixagevimab / cilgavimab as pre-exposure prophy-laxis against infection from SARS-CoV-2 and severe COVID-19 among heavily immunocompromised patients: a single-center, prospective, real-world study.

Efficacy of tixagevimab / cilgavimab as pre-exposure prophy-laxis against infection from SARS-CoV-2 and severe COVID-19 among heavily immunocompromised patients: a single-center, prospective, real-world study.

URI: https://www.openarchives.gr/aggregator-openarchives/edm/pergamos/000005-uoadl%3A3405734
RDF/XML JSON-LD

This item is provided by the institution :
/aggregator-openarchives/portal/institutions/uoa

Repository :
Πέργαμος

see the original item page
in the repository's web site and access all digital files if the item^*

Title

Efficacy of tixagevimab / cilgavimab as pre-exposure prophy-laxis against infection from SARS-CoV-2 and severe COVID-19 among heavily immunocompromised patients: a single-center, prospective, real-world study.

Creator

Dimitrios Basoulis1*, Elpida Mastrogianni2, Georgios Karamanakos3, Aikaterini Gkoufa1, Vasiliki E. Georgakopou-lou1, Sotiria Makrodimitri1, Maria N. Gamaletsou1, Antonios Markogiannkis4, Nikolaos V. Sipsas1

Type

research_data_set

Σύνολο ερευνητικών δεδομένων (EL)

Research data set (EN)

Dataset (EN)

Date

2024

Year

2024 (EL)

Scientific field

Επιστήμες Υγείας

Ιατρική και Επιστήμες Υγείας
Health Sciences (EN)

Subject

Επιστήμες Υγείας (EL)

Health Sciences (EN)

Language

English

School / Department / Institute

Σχολή Επιστημών Υγείας » Τμήμα Ιατρικής

Rights

https://creativecommons.org/licenses/by-nc/4.0/

Provider

Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών

Repository / collection

Πέργαμος

Subcollections

Research data set

Efficacy of tixagevimab / cilgavimab as pre-exposure prophy-laxis against infection from SARS-CoV-2 and severe COVID-19 among heavily immunocompromised patients: a single-center, prospective, real-world study.

Βοηθείστε μας να κάνουμε καλύτερο το OpenArchives.gr.